Haemonetics Newsroom

Positive Earnings Growth Hasn't Been Enough to Get Haemonetics (NYSE:HAE) Shareholders a Favorable Return Over the Last Five Years

Simply Wall St13:31 ET

How Do Investors Really Feel About Haemonetics?

BenzingaApr 23 09:00 ET

Vivasure Medical Announces European CE Mark Approval Of PerQseal Elite Vascular Closure System

BenzingaApr 22 09:38 ET

Highland Arms Enterprises Acquires Camprendy

PR NewswireApr 10 12:01 ET

Express News | Haemonetics Corp : Citigroup Cuts Target Price to $71 From $72

ReutersApr 7 07:17 ET

An Intrinsic Calculation For Haemonetics Corporation (NYSE:HAE) Suggests It's 49% Undervalued

Simply Wall StApr 4 06:37 ET

Haemonetics Corp. (HAE): Among the 10 Pro-Life Companies to Invest In Now?

Yahoo FinanceApr 1 08:43 ET

Haemonetics Sets Date for Publishing Fourth Quarter and Fiscal Year 2025 Results: May 8, 2025

PR NewswireMar 31 16:00 ET

Hospital Stocks Are Ready to Rebound, Deutsche Bank Says

BNN BloombergMar 25 13:51 ET

Proposed Medicaid Cuts Would Devastate Local Economies: Report -- Barrons.com

Barron'sMar 25 00:01 ET

A Note On Haemonetics Corporation's (NYSE:HAE) ROE and Debt To Equity

Yahoo FinanceMar 24 06:41 ET

Needham Maintains Haemonetics(HAE.US) With Buy Rating, Cuts Target Price to $104

Moomoo NewsMar 19 01:32 ET · Ratings

Is It Apt to Retain HAE Stock in Your Portfolio for Now?

Zacks Mar 18 11:00 ET

Demystifying Haemonetics: Insights From 5 Analyst Reviews

BenzingaMar 18 08:01 ET

Haemonetics Price Target Lowered to $104 From $108 at Needham

TipRanksMar 18 07:30 ET

Haemonetics Is Maintained at Buy by Needham

Dow JonesMar 18 06:44 ET · Ratings

Haemonetics Analyst Ratings

BenzingaMar 18 06:31 ET · Ratings

Express News | Haemonetics Corp : Needham Cuts Target Price to $104 From $108

ReutersMar 18 06:10 ET

Healthcare Up as Traders Rotate to Less Inflation-Sensitive Sectors -- Health Care Roundup

Dow JonesMar 17 16:53 ET

Investors Appear Satisfied With Haemonetics Corporation's (NYSE:HAE) Prospects

Simply Wall StMar 10 10:52 ET